Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Zoetis Inc    ZTS

SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
 News SummaryMost relevantAll newsSector newsTweets 
Most relevant news about ZOETIS INC
02/17 ZOETIS : Statement on the Positive Opinion for Cytopoint Adopted by the European..
02/17 ZOETIS : to Participate in the Cowen and Company 37th Annual Health Care Confere..
02/16DJZOETIS : Dims Outlook
02/16 ZOETIS : tops 4Q profit forecasts
02/16 ZOETIS : Reports Fourth Quarter and Full Year 2016 Results
02/15 ZOETIS : Receives European Commission Approval for Stronghold® Plus
02/15 ZOETIS INC. (NYSE : ZTS) Files An 8-K Regulation FD Disclosure
02/14 ZOETIS : Declares Second Quarter 2017 Dividend
02/13ZOETIS INC : annual earnings release
01/30 ANATARA LIFESCIENCES LTD (ASX : ANR) Receives Second Payment for Detach Under Th..
01/11 ZOETIS : Colleagues Make a Difference in Their Communities
01/03 ZOETIS : PHARMAQ Acquires Fish Vaccination Company Nordland Sett Vaks
2016 ZOETIS : to Host Webcast and Conference Call on Fourth Quarter and Full Year 201..
2016 ZOETIS : joins GlobalVetLINK’s VFD system
2016 ZOETIS INC. (NASDAQ : ZTS) Files An 8-K Entry into a Material Definitive Agreeme..
More most relevant news
All news about ZOETIS INC
02/25 FDA Issues Final Rule for New Animal Drugs for Use in Animal Feed
02/24 PHIBRO ANIMAL HEALTH : New Animal Drugs for Use in Animal Feed; Approval of New ..
02/24 ZOETIS : Reports Fourth Quarter and Full Year 2016 Results
02/17 ZOETIS : Statement on the Positive Opinion for Cytopoint Adopted by the European..
02/17 ZOETIS : to Participate in the Cowen and Company 37th Annual Health Care Confere..
02/16 ZOETIS : Management's Discussion and Analysis of Financial Condition and Results..
02/16DJZOETIS : Dims Outlook
02/16 ZOETIS : tops 4Q profit forecasts
02/16 ZOETIS INC. : Results of Operations and Financial Condition, Financial Statement..
02/16 ZOETIS : Reports Fourth Quarter and Full Year 2016 Results
More news
Sector news : Veterinary Drugs
02/24DJSHIRE : Files 8K - Other Events
02/24DJASTRAZENECA : Hyperkalaemia Drug Clears Scientific Hurdle for European Approval
02/24DJASTRAZENECA : Gets Approval for Drug Treating Hyperkalaemia
02/24 Exclusive - Trump says Republican border tax could boost U.S. jobs
02/23DJPFIZER : Files 8K - Changes Executive Management
02/23DJGlaxoSmithKline Reports Positive Study Results for Asthma Drug
More sector news : Veterinary Drugs
News from SeekingAlpha
02/23 PHIBRO ANIMAL HEALTH : Good Company, Good Performance, Questionable Price
02/17 Tracking George Soros's Portfolio - Q4 2016 Update
02/16 Zoetis (ZTS) Q4 2016 Results - Earnings Call Transcript
02/16 Zoetis earnings up 142%; non-GAAP EPS up 11% in FY16; updates 2017 guidance
02/16 Tracking Bill Ackman's Pershing Square Portfolio - Q4 2016 Update
02/16 Zoetis 2016 Q4 - Results - Earnings Call Slides
Latest Tweets
01:22pZoetis Inc $ZTS Shares Bought by Raymond James Financial Services Advisors In.. 
02/23Phibro Animal Health: Good Company, Good Performance, Questionable Price  
02/22Fox News bureau - Denver. Photo credit: @david_glenn_smith
44
02/20Zoetis Inc $ZTS Forecasted to Post FY2021 Earnings of $3.90 Per Share  
02/20Zoetis Inc $ZTS Releases FY17 Earnings Guidance  
More tweets
Qtime:62
Advertisement
Financials ($)
Sales 2017 5 167 M
EBIT 2017 1 786 M
Net income 2017 1 076 M
Debt 2017 2 049 M
Yield 2017 0,78%
P/E ratio 2017 25,36
P/E ratio 2018 20,91
EV / Sales 2017 5,53x
EV / Sales 2018 5,16x
Capitalization 26 507 M
More Financials
Chart ZOETIS INC
Duration : Period :
Zoetis Inc Technical Analysis Chart | ZTS | US98978V1035 | 4-Traders
Full-screen chart
Technical analysis trends ZOETIS INC
Short TermMid-TermLong Term
TrendsBearishBullishBullish
Technical analysis
Income Statement Evolution
More Financials
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 19
Average target price 59,1 $
Spread / Average Target 9,7%
Consensus details
EPS Revisions
More Estimates Revisions
Managers
NameTitle
Juan Ramón Alaix President, Chief Executive Officer & Director
Mike B. McCallister Non-Executive Chairman
Kristin C. Peck Executive Vice President & President-US Operations
Glenn David Chief Financial Officer & Executive Vice President
Catherine Ann Knupp Executive VP, President-Research & Development
More about the company
Sector and Competitors
1st jan.Capitalization (M$)
ZOETIS INC0.09%26 507
JINYU BIO-TECHNOLOGY C..49.34%3 073
DECHRA PHARMACEUTICALS..14.50%1 786
SHANGHAI HILE BIO TECH..-4.71%1 593
VIRBAC2.57%1 530
PULIKE BIOLOGICAL ENGI..8.52%1 238
More Results